Apolipoprotein A5 polymorphisms and risk of coronary artery disease: A meta-analysis

BioScience Trends

Volumn 5, Issue 4, 2011, Pages 165-172

  Zhang, Zhen ^a   Peng, Bo ^b   Gong, Renrong ^c   Gao, Linbo ^d   Du, Juan ^a   Fang, Dingzhi ^a   Song, Yongyan ^a   Li, Yuanhao ^a   Ou, Guojing ^a  

^a SICHUAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c SICHUAN UNIVERSITY   (China)

^d SICHUAN UNIVERSITY   (China)

Author keywords

Apolipoprotein A5; Coronary artery disease; Gene polymorphism; Meta analysis

Indexed keywords

APOA5 PROTEIN, HUMAN; APOLIPOPROTEIN A; TRIACYLGLYCEROL;

ALLELE; ARTICLE; ASIAN; BLOOD; CORONARY ARTERY DISEASE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; META ANALYSIS; PROMOTER REGION; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

ALLELES; APOLIPOPROTEINS A; ASIAN CONTINENTAL ANCESTRY GROUP; CORONARY ARTERY DISEASE; DATA INTERPRETATION, STATISTICAL; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RISK; TRIGLYCERIDES;

EID: 84863115298     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: 10.5582/bst.2011.v5.4.165     Document Type: Article

References (36)

1. Wang Q. Molecular genetics of coronary artery disease. Curr Opin Cardiol. 2005; 20:182-188.
2. Cullen P. Evidence that triglycerides are an independent coronary heart disease risk factor. Am J Cardiol. 2000; 86:943-949.
3. Talmud PJ, Hawe E, Miller GJ, Humphries SE. Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middleaged UK men. Arterioscler Thromb Vasc Biol. 2002; 22:1918-1923.
4. Heller DA, de Faire U, Pedersen NL, Dahlen G, McClearn GE. Genetic and environmental influences on serum lipid levels in twins. N Engl J Med. 1993; 328:1150-1156.
5. van Dijk KW, Rensen PC, Voshol PJ, Havekes LM. The role and mode of action of apolipoproteins CIII and AV: Synergistic actors in triglyceride metabolism? Curr Opin Lipidol. 2004; 15:239-246.
6. Pennacchio LA, Olivier M, Hubacek JA, Cohen JC, Cox DR, Fruchart JC, Krauss RM, Rubin EM. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science. 2001; 294:169-173.
7. van der Vliet HN, Sammels MG, Leegwater AC, Levels JH, Reitsma PH, Boers W, Chamuleau RA. Apolipoprotein A-V: A novel apolipoprotein associated with an early phase of liver regeneration. J Biol Chem. 2001; 276:44512-44520.
8. Li GP, Wang JY, Yan SK, Chen BS, Xue H, Wu G. Genetic effect of two polymorphisms in the apolipoprotein A5 gene and apolipoprotein C3 gene on serum lipids and lipoproteins levels in a Chinese population. Clin Genet. 2004; 65:470-476.
9. Pennacchio LA, Olivier M, Hubacek JA, Krauss RM, Rubin EM, Cohen JC. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet. 2002; 11:3031-3038.
10. Vaessen SF, Schaap FG, Kuivenhoven JA, et al. Apolipoprotein A-V, triglycerides and risk of coronary artery disease: The prospective Epic-Norfolk Population Study. J Lipid Res. 2006; 47:2064-2070.
11. Bi N, Yan SK, Li GP, Yin ZN, Chen BS. A single nucleotide polymorphism - 1131T>C i n t h e apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and alters triglyceride metabolism in Chinese. Mol Genet Metab. 2004; 83:280-286.
12. Szalai C, Keszei M, Duba J, Prohaszka Z, Kozma GT, Csaszar A, Balogh S, Almassy Z, Fust G, Czinner A. Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease. Atherosclerosis. 2004; 173:109-114.
13. Lai CQ, Demissie S, Cupples LA, Zhu Y, Adiconis X, Parnell LD, Corella D, Ordovas JM. Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study. J Lipid Res. 2004; 45:2096-2105.
14. Liu H, Zhang S, Lin J, Li H, Huang A, Xiao C, Li X, Su Z, Wang C, Nebert DW, Zhou B, Zheng K, Shi J, Li G, Huang D. Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese. Metabolism. 2005; 54:568-572.
15. Lee KW, Ayyobi AF, Frohlich JJ, Hill JS. APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease. Atherosclerosis. 2004; 176:165-172.
16. Prochaska CL, Picheth G, Anghebem-Oliveira MI, Costantini CO, de Souza EM, Pedrosa FO, Scartezini M. The polymorphisms -1131T>C and the S19W of the APOA5 gene are not associated with coronary artery disease in a Brazilian population. Clin Chem Lab Med. 2010; 48:419-422.
17. Martinelli N, Trabetti E, Bassi A, Girelli D, Friso S, Pizzolo F, Sandri M, Malerba G, Pignatti PF, Corrocher R, Olivieri O. The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: An angiographic study. Atherosclerosis. 2007; 191:409-417.
18. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet. 1955; 19:251-253.
19. Cochran W. The combination of estimates from different experiments. Biometrics. 1954; 10:101-129.
20. DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: An update. Contemporary clinical trials. 2007; 28:105-114.
21. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959; 22:719-748.
22. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003; 327:557-560.
23. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50:1088-1101.
24. Egger M, Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315:629-634.
25. Ioannidis J, Trikalinos T. Early extreme contradictory estimates may appear in published research: The Proteus phenomenon in molecular genetics research and randomized trials. Journal of clinical epidemiology. 2005; 58:543-549.
26. Hsu LA, Ko YL, Chang CJ, Hu CF, Wu S, Teng MS, Wang CL, Ho WJ, Ko YS, Hsu TS, Lee YS. Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan. Atherosclerosis. 2006; 185:143-149.
27. Hubacek JA, Skodova Z, Adamkova V, Lanska V, Poledne R. The influence of APOAV polymorphisms (T-1131>C and S19>W) on plasma triglyceride levels and risk of myocardial infarction. Clin Genet. 2004; 65:126-130.
28. Tang YB, Sun P, Guo DP, Li XY, Chen Q, Fan LM. Association between apolipoprotein A5 - 1131T > C polymorphism and susceptibility of coronary artery disease in Chinese. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2005; 22:281-283.
29. Yan SK, Cheng XQ, Song YH, Xiao XH, Bi N, Chen BS. Apolipoprotein A5 gene polymorphism -1131T-->C: Association with plasma lipids and type 2 diabetes mellitus with coronary heart disease in Chinese. Clin Chem Lab Med. 2005; 43:607-612.
30. Yu Y, Xue L, Zhao CY. Study on polymorphism in the apolipoprotein A5 gene in patients with premature coronary heart disease. Beijing Da Xue Xue Bao. 2007; 39:576-580. (in Chinese)
31. Ashokkumar M, Subhashini NG, Saibabu R, Ramesh A, Cherian KM, Emmanuel C. Genetic variants on apolipoprotein gene cluster influence triglycerides with a risk of coronary artery disease among Indians. Mol Biol Rep. 2010; 37:521-527.
32. Jang Y, Paik JK, Hyun YJ, Chae JS, Kim JY, Choi JR, Lee SH, Shin DJ, Ordovas JM, Lee JH. The apolipoprotein A5 -1131T>C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease. Clin Chim Acta. 2009; 402:83-87.
33. Park JY, Paik JK, Kim OY, Chae JS, Jang Y, Lee JH. Interactions between the APOA5 -1131T>C and the FEN1 10154G>T polymorphisms on {omega}6 polyunsaturated fatty acids in serum phospholipids and coronary artery disease. J Lipid Res. 2010; 51:3281-3288.
34. Dallongeville J, Cottel D, Montaye M, Codron V, Amouyel P, Helbecque N. Impact of APOA5/A4/C3 genetic polymorphisms on lipid variables and cardiovascular disease risk in French men. Int J Cardiol. 2006; 106:152-156.
35. Zhao T, Zhao J. Association of the apolipoprotein A5 gene -1131 T>C polymorphism with fasting blood lipids: A meta-analysis in 37,859 subjects. BMC Med Genet. 2010; 11:120.
36. He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, Wang J, Chen CS, Chen J, Wildman RP, Klag MJ, Whelton PK. Major causes of death among men and women in China. N Engl J Med. 2005; 353:1124-1134.